Farallon Capital Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,350,000	Closed	-$11.4M	–	133
2020 Q1	$11.4M	Hold	2,350,000	–	–	0.1%	75
2019 Q4	$25M	Buy	2,350,000 +50,000	+2%	+$532K	0.17%	73
2019 Q3	$23.9M	Buy	2,300,000 +800,000	+53%	+$8.33M	0.18%	67
2019 Q2	$23M	Sell	1,500,000 -500,000	-25%	-$7.66M	0.15%	72
2019 Q1	$25.7M	Buy	+2,000,000	New	+$25.7M	0.19%	63
2017 Q4	–	Sell	-1,187,500	Closed	-$13.2M	–	93
2017 Q3	$13.2M	Buy	1,187,500 +30,000	+3%	+$333K	0.12%	64
2017 Q2	$10.6M	Sell	1,157,500 -10,000	-0.9%	-$92K	0.11%	63
2017 Q1	$9.98M	Buy	1,167,500 +910,000	+353%	+$7.78M	0.11%	60
2016 Q4	$2.76M	Buy	+257,500	New	+$2.76M	0.03%	63
2015 Q4	–	Sell	-676,162	Closed	-$5.97M	–	81
2015 Q3	$5.97M	Buy	676,162 +3,600	+0.5%	+$31.8K	0.08%	65
2015 Q2	$7.92M	Hold	672,562	–	–	0.11%	71
2015 Q1	$9.73M	Buy	672,562 +577,562	+608%	+$8.36M	0.14%	68
2014 Q4	$1.62M	Hold	95,000	–	–	0.02%	77
2014 Q3	$1.18M	Hold	95,000	–	–	0.02%	76
2014 Q2	$1.39M	Hold	95,000	–	–	0.02%	87
2014 Q1	$1.93M	Hold	95,000	–	–	0.04%	74
2013 Q4	$1.86M	Buy	95,000 +36,000	+61%	+$706K	0.04%	71
2013 Q3	$2.67M	Sell	59,000 -76,000	-56%	-$3.44M	0.05%	72
2013 Q2	$3.22M	Buy	+135,000	New	+$3.22M	0.06%	71